ÇѸ²´ëÇб³¼º½Éº´¿ø

Á¶»óÈ£ ±³¼ö

  • Àü¹®¼¾ÅÍ ½ÉÀåÇ÷°ü¼¾ÅÍ
  • Áø·á°ú ¼øȯ±â³»°ú

Àü¹®Áø·áºÐ¾ß

°ü»óµ¿¸Æ È®Àå¼ú/½ºÅÙÆ®»ðÀÔ¼ú, ½É±Ù°æ»öÁõ, Çù½ÉÁõ, ÀúÇ×¼º°íÇ÷¾Ð, °íÁöÇ÷Áõ, ½ÉºÎÀü, ÈäÅë, È£Èí°ï¶õ, µ¿¸Æ°æÈ­Áõ

ÀüÈ­ ¿¹¾à 1577-1801
±³¼ö´Ô»çÁø

(ÁÖ°£) Áø·á½Ã°£Ç¥ (2024-10-14 ~ 2024-10-19)

Áø·á½Ã°£Ç¥
Áø·á½Ã°£ ¿ù È­ ¼ö ¸ñ ±Ý Åä
¿ÀÀü ¼¾ÅÍÁø·á¼¾ÅÍÁø·á
¿ÀÈÄ ÈÞÁø
±³¼ö´Ô »çÁø

±âº»Á¤º¸

ÇзÂ

ÇзÂ

2009.03 ~ 2011.02¼­¿ï´ëÇб³ ´ëÇпø ¹Ú»ç

2002.09 ~ 2004.08¼­¿ï´ëÇб³ ´ëÇпø ¼®»ç

1990.03 ~ 1997.02¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ Çлç

°æ·Â

°æ·Â

2006.03 ~ ÇѸ²´ë¼º½Éº´¿ø ¼øȯ±â³»°ú ±³¼ö

2004.03 ~ 2006.02¼­¿ï´ëÇб³º´¿ø ¼øȯ±â³»°ú ÀÓ»ó°­»ç

2000.03 ~ 2004.02¼­¿ï´ëÇб³º´¿ø ³»°ú Àü°øÀÇ

1998.03 ~ 1999.02¼­¿ï´ëÇб³º´¿ø ÀÎÅÏ

ÇÐȸȰµ¿

ÇÐȸȰµ¿

2021 ~ 2023´ëÇÑ ½ÉºÎÀüÇÐȸ Á¤Ã¥ ÀÌ»ç

2020 ~ 2023´ëÇÑ °íÇ÷¾ÐÇÐȸ ´ë»çÁõÈıº ¿¬±¸È¸ Ãѹ«ÀÌ»ç, ÇмúÀÌ»ç

2020 ~ 2023´ëÇÑ ½É³úÇ÷°ü¿¹¹æÇÐȸ ÀÌ»óÁöÁúÇ÷ÁõºÐ°ú ÀÌ»ç

2020 ~ 2023´ëÇÑ ½ÉÀåÇÐȸ Çмú À§¿ø

2020 ~ 2023´ëÇÑ °íÇ÷¾ÐÇÐȸ °£ÇàÀ§¿ø

2019 ~ 2023´ëÇÑ ½ÉÀå´ë»çÁõÈıºÇÐȸ ÇмúÀÌ»ç, Ãѹ«ÀÌ»ç

2019 ~ 2023ÁöÁúµ¿¸Æ°æÇÐȸ °£ÇàÀ§¿ø

2019 ~ 2021½ÉÇ÷°üÁßÀçÇÐȸ È«º¸À§¿ø

¼ö»óÀÌ·Â

¼ö»óÀÌ·Â

2021.03´ëÇѽɳúÇ÷°ü¿¹¹æÇÐȸ ¿¬±¸ºñ ¼öÇý

2020.03Áß¼Ò±â¾÷û ¿¬±¸ºñ ¼öÇý

2018.03´ëÇѽÉÇ÷°üÁßÀçÇÐȸ ¿¬±¸ºñ ¼öÇý

2015.03»ê¾÷Åë»óÀÚ¿øºÎ ¿¬±¸ºñ ¼öÇý

2009.03´ëÇÑ ¼øȯ±âÇÐȸ ¿¬±¸ºñ ¼öÇý

³í¹®

Articles Within 1 years as First or Corresponding Author (Sep. 2020. – Sep. 2021.)




1: Kim HL, Jo SH. Current Evidence on Long-Term Prognostic Factors in

Vasospastic Angina. J Clin Med. 2021 Sep 21;10(18):4270. doi:

10.3390/jcm10184270. PMID: 34575381; PMCID: PMC8469875.

[Corresponding author, SCI IF 4.241]



2: Kim HJ, Lee MH, Jo SH, Seo WW, Kim HL, Lee KY, Yang TH, Her SH, Han SH, Lee

BK, Park KH, Rha SW, Gwon HC, Choi DJ, Baek SH. Effect of Significant Coronary

Artery Stenosis on Prognosis in Patients with Vasospastic Angina: A Propensity

Score-Matched Analysis. J Clin Med. 2021 Jul 28;10(15):3341. doi:

10.3390/jcm10153341. PMID: 34362125; PMCID: PMC8347544.

[Corresponding author, SCI IF 4.241]



3: Jo SH, Nam H, Lee J, Park S, Lee J, Kyoung DS. Fenofibrate Use Is Associated

With Lower Mortality and Fewer Cardiovascular Events in Patients With Diabetes:

Results of 10,114 Patients From the Korean National Health Insurance Service

Cohort. Diabetes Care. 2021 Aug;44(8):1868-1876. doi: 10.2337/dc20-1533. Epub

2021 Jun 22. PMID: 34158362.

[First and Corresponding author, SCI IF 19.112]



4. Cho SS, Jo SH, Kim HJ, Lee MH, Seo WW, Kim HL, Lee KY, Yang TH, Her SH, Han

SH, Lee BK, Park KH, Rha SW, Gwon HC, Choi DJ, Baek SH. Smoking may be more

harmful to vasospastic angina patients who take antiplatelet agents due to the

interaction: Results of Korean prospective multi-center cohort. PLoS One. 2021

Apr 2;16(4):e0248386. doi: 10.1371/journal.pone.0248386. PMID: 33798225; PMCID:

PMC8018640.

[Corresponding author, SCI IF 3.240]



5: Seo WW, Jo SH, Kim SE, Kim HJ, Han SH, Lee KY, Her SH, Lee MH, Cho SS, Kim

HL, Baek SH. Admission serum potassium levels and prognosis of vasospastic

angina. Sci Rep. 2021 Mar 11;11(1):5707. doi: 10.1038/s41598-021-84712-w. PMID:

33707512; PMCID: PMC7952915.

[Corresponding author, SCI IF 4.379]



6: Jo SH, Han SH, Kim SH, Eckel RH, Koh KK. Cardiovascular effects of omega-3

fatty acids: Hope or hype? Atherosclerosis. 2021 Apr;322:15-23. doi:

10.1016/j.atherosclerosis.2021.02.014. Epub 2021 Feb 23. PMID: 33706079.

[First author, SCI IF 3.919]



7: Jo SH. Iso-osmolar Iodixanol Is Better than Low-osmolar Contrast for CIN

Prevention. And Then? Korean Circ J. 2021 Feb;51(2):182-184. doi:

10.4070/kcj.2021.0003. PMID: 33525074; PMCID: PMC7853893.

[First and Corresponding author, SCI IF 3.243]



8: Jeong HS, Lim HS, Park HJ, Lee WS, Choi JO, Lee HS, Jo SH, Hong SJ. Clinical

outcomes between calcium channel blockers and angiotensin receptor blockers in

hypertensive patients without established cardiovascular diseases during a

3-year follow-up. Sci Rep. 2021 Jan 19;11(1):1783. doi:

10.1038/s41598-021-81373-7. PMID: 33469103; PMCID: PMC7815918.

[Corresponding author, SCI IF 4.379]



9: Jo SH. Renal Denervation, Come Back Time? Korean Circ J. 2021

Jan;51(1):56-57. doi: 10.4070/kcj.2020.0479. PMID: 33377329; PMCID: PMC7779822.

[First and Corresponding author, SCI IF 3.243]



10: Kim HL, Jo SH, Kim HJ, Lee MH, Seo WW, Baek SH. Sex differences in clinical

characteristics and long-term outcomes in patients with vasospastic angina:

results from the VA-Korea registry, a prospective multi-center cohort. Biol Sex

Differ. 2020 Nov 23;11(1):66. doi: 10.1186/s13293-020-00341-4. PMID: 33228754;

PMCID: PMC7684896.

[Corresponding author, SCI IF 4.54]



11: Jo SH, Park SJ, Hong GR, Kim SW, Park CG. Telmisartan Plus S-Amlodipine

Single-Pill Combination Therapy is Safe and Effective in Patients with

Hypertension from Large-Scale Nationwide Surveillance Data in Korea (NOVEL)

Study. Adv Ther. 2021 Jan;38(1):304-315. doi: 10.1007/s12325-020-01533-5. Epub

2020 Oct 27. PMID: 33108624.

[First author, SCI IF 3.871]



12: Kim HJ, Jo SH, Lee MH, Seo WW, Baek SH. Hyperthyroidism Is Associated with

the Development of Vasospastic Angina, but Not with Cardiovascular Outcomes. J

Clin Med. 2020 Sep 19;9(9):3020. doi: 10.3390/jcm9093020. PMID: 32961722; PMCID:

PMC7565955. [Corresponding author, SCI IF 4.241]



13: Kim HJ, Jo SH, Lee MH, Seo WW, Choi JO, Ryu KH. The effect of beta-blockers

in acute heart failure according to heart rate. Korean J Intern Med. 2021

Jul;36(4):898-905. doi: 10.3904/kjim.2020.270. Epub 2020 Sep 21. PMID: 32872744;

PMCID: PMC8273820. [Corresponding author, SCI IF 2.884]



=====Authors as participating in below article within 1 year =====

14: Koo BK, Kang J, Park KW, Rhee TM, Yang HM, Won KB, Rha SW, Bae JW, Lee NH,

Hur SH, Yoon J, Park TH, Kim BS, Lim SW, Cho YH, Jeon DW, Kim SH, Han JK, Shin

ES, Kim HS; HOST-EXAM investigators. Aspirin versus clopidogrel for chronic

maintenance monotherapy after percutaneous coronary intervention (HOST-EXAM): an

investigator-initiated, prospective, randomised, open-label, multicentre trial.

Lancet. 2021 Jun 26;397(10293):2487-2496. doi: 10.1016/S0140-6736(21)01063-1.

Epub 2021 May 16. PMID: 34010616.

[Author, SCI IF 79.3]



15: Lam CSP, Giczewska A, Sliwa K, Edelmann F, Refsgaard J, Bocchi E, Ezekowitz

JA, Hernandez AF, O'Connor CM, Roessig L, Patel MJ, Pieske B, Anstrom KJ,

Armstrong PW; VICTORIA Study Group. Clinical Outcomes and Response to Vericiguat

According to Index Heart Failure Event: Insights From the VICTORIA Trial. JAMA

Cardiol. 2021 Jun 1;6(6):706-712. doi: 10.1001/jamacardio.2020.6455. Erratum in:

JAMA Cardiol. 2021 Jan 13;: Erratum in: JAMA Cardiol. 2021 Jun 1;6(6):728.

Erratum in: JAMA Cardiol. 2021 Oct 6;:null. PMID: 33185650; PMCID: PMC7666431.

[Author, SCI IF 12.8]

°Ç°­¸Å°ÅÁø